Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

STRATA Skin Sciences (SSKN) Invested Capital (2016 - 2025)

STRATA Skin Sciences' Invested Capital history spans 15 years, with the latest figure at $18.3 million for Q4 2025.

  • On a quarterly basis, Invested Capital rose 267.2% to $18.3 million in Q4 2025 year-over-year; TTM through Dec 2025 was $18.3 million, a 267.2% increase, with the full-year FY2025 number at $18.3 million, up 267.2% from a year prior.
  • Invested Capital hit $18.3 million in Q4 2025 for STRATA Skin Sciences, up from $3.2 million in the prior quarter.
  • Over the last five years, Invested Capital for SSKN hit a ceiling of $26.2 million in Q3 2021 and a floor of $532000.0 in Q2 2025.
  • Historically, Invested Capital has averaged $15.8 million across 5 years, with a median of $17.6 million in 2023.
  • The widest YoY moves for Invested Capital: up 267.2% in 2025, down 94.4% in 2025.
  • Tracing SSKN's Invested Capital over 5 years: stood at $25.4 million in 2021, then decreased by 14.1% to $21.8 million in 2022, then plummeted by 41.88% to $12.7 million in 2023, then plummeted by 60.81% to $5.0 million in 2024, then surged by 267.2% to $18.3 million in 2025.
  • Business Quant data shows Invested Capital for SSKN at $18.3 million in Q4 2025, $3.2 million in Q3 2025, and $532000.0 in Q2 2025.